Literature DB >> 18324879

The safety of diclofenac for the management and treatment of actinic keratoses.

Fariba Iraji1, Amir Hossein Siadat, Ali Asilian, Shahla Enshaieh, Zabiholah Shahmoradi.   

Abstract

BACKGROUND: Actinic keratoses (AKs), defined as carcinoma in situ of squamous carcinoma, is usually induced by excessive sun exposure. The efficacy of 3% diclofenac in 2.5% hyaluronic acid gel for treatment of AKs has been documented in a few studies.
OBJECTIVE: Is diclofenac safe and effective for the management and treatment of AKs?
METHOD: All the papers that were cited in Medline and ISI Web of Science are included in this study. RESULTS/
CONCLUSION: The use of diclofenac is associated with a few side effects, which include pruritus, rashes, dry skin, and scaling. These side effects are usually minimal and tolerable; therefore, this topical medication is suggested as the first line of treatment for AKs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324879     DOI: 10.1517/14740338.7.2.167

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  4 in total

Review 1.  [Actinic keratoses. Pathogenesis, clinical aspect and modern therapeutic options].

Authors:  T Strunk; R-M Szeimies
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

Review 2.  [The aged scalp : A dermato-oncological focus point].

Authors:  N Wroblewski; K Wylon; C Ulrich
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

Review 3.  [Actinic keratoses].

Authors:  T Hommel; R-M Szeimies
Journal:  Hautarzt       Date:  2016-11       Impact factor: 0.751

Review 4.  Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data.

Authors:  Cristina Scavone; Angela Colomba Bonagura; Sonia Fiorentino; Daniela Cimmaruta; Rosina Cenami; Marco Torella; Tiziano Fossati; Francesco Rossi
Journal:  Drugs R D       Date:  2016-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.